TLIS 2-DAY DEADLINE ALERT: Hagens Berman, National Trial Attorneys, Encourages Talis Biomedical Corporation (TLIS) Investors with Losses to Contact Firm’s Attorneys Before Application Deadline in Securities Class Action
March 06, 2022 12:27 ET
|
Hagens Berman Sobol Shapiro LLP
SAN FRANCISCO, March 06, 2022 (GLOBE NEWSWIRE) -- Hagens Berman urges Talis Biomedical Corporation (NASDAQ: TLIS) investors with significant losses to submit your losses now. A securities class...
TLIS 8-DAY DEADLINE ALERT: Hagens Berman, National Trial Attorneys, Encourages Talis Biomedical Corporation (TLIS) Investors with Losses to Contact Firm’s Attorneys Before Mar. 8th Deadline
February 28, 2022 13:53 ET
|
Hagens Berman Sobol Shapiro LLP
SAN FRANCISCO, Feb. 28, 2022 (GLOBE NEWSWIRE) -- Hagens Berman urges Talis Biomedical Corporation (NASDAQ: TLIS) investors with significant losses to submit your losses now. A securities class...
HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages Talis Biomedical Corporation (TLIS) Investors with Losses to Contact Firm’s Attorneys, Deadline Approaching in Securities Class Action
February 22, 2022 09:31 ET
|
Hagens Berman Sobol Shapiro LLP
SAN FRANCISCO, Feb. 22, 2022 (GLOBE NEWSWIRE) -- Hagens Berman urges Talis Biomedical Corporation (NASDAQ: TLIS) investors with significant losses to submit your losses now. A securities class...
TLIS DEADLINE ALERT: Hagens Berman, National Trial Attorneys, Encourages Talis Biomedical Corporation (TLIS) Investors with Losses to Contact Firm’s Attorneys About Lead Plaintiff Opportunity
February 14, 2022 09:37 ET
|
Hagens Berman Sobol Shapiro LLP
SAN FRANCISCO, Feb. 14, 2022 (GLOBE NEWSWIRE) -- Hagens Berman urges Talis Biomedical Corporation (NASDAQ: TLIS) investors with significant losses to submit your losses now. A securities class...
TLIS INVESTOR ALERT: Hagens Berman, National Trial Attorneys, Encourages Talis Biomedical Corporation (TLIS) Investors with Losses to Contact Firm’s Attorneys, Securities Fraud Action Pending
February 07, 2022 18:54 ET
|
Hagens Berman Sobol Shapiro LLP
SAN FRANCISCO, Feb. 07, 2022 (GLOBE NEWSWIRE) -- Hagens Berman urges Talis Biomedical Corporation (NASDAQ: TLIS) investors with significant losses to submit your losses now. A securities class...
TLIS INVESTOR ALERT: Hagens Berman, National Trial Attorneys, Encourages Talis Biomedical Corporation (TLIS) Investors with Losses to Contact Firm’s Attorneys, Securities Class Action Filed
January 31, 2022 13:35 ET
|
Hagens Berman Sobol Shapiro LLP
SAN FRANCISCO, Jan. 31, 2022 (GLOBE NEWSWIRE) -- Hagens Berman urges Talis Biomedical Corporation (NASDAQ: TLIS) investors with significant losses to submit your losses now. A securities class...
TLIS INVESTOR FRAUD: Hagens Berman, National Trial Attorneys, Encourages Talis Biomedical Corporation (TLIS) Investors with Losses to Contact Firm’s Attorneys, Securities Class Action Filed
January 24, 2022 09:37 ET
|
Hagens Berman Sobol Shapiro LLP
SAN FRANCISCO, Jan. 24, 2022 (GLOBE NEWSWIRE) -- Hagens Berman urges Talis Biomedical Corporation (NASDAQ: TLIS) investors with significant losses to submit your losses now. A securities class...
HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages Talis Biomedical Corporation (TLIS) Investors with Losses to Contact Firm’s Attorneys, IPO-Related Securities Class Action Filed
January 18, 2022 13:22 ET
|
Hagens Berman Sobol Shapiro LLP
SAN FRANCISCO, Jan. 18, 2022 (GLOBE NEWSWIRE) -- Hagens Berman urges Talis Biomedical Corporation (NASDAQ: TLIS) investors with significant losses to submit your losses now. A securities class...
HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages Talis Biomedical Corporation (TLIS) Investors to Contact Firm’s Attorneys, IPO-Related Securities Class Action Filed
January 11, 2022 19:03 ET
|
Hagens Berman Sobol Shapiro LLP
SAN FRANCISCO, Jan. 11, 2022 (GLOBE NEWSWIRE) -- Hagens Berman urges Talis Biomedical Corporation (NASDAQ: TLIS) investors with significant losses to submit your losses now. A securities class...